ViroGates A/S
Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.
VIRO | ST
Overview
Corporate Details
- ISIN(s):
- DK0061030574
- LEI:
- 5493007TX8XS56RMZD94
- Country:
- Denmark
- Address:
- Banevænget 13 1., 3460 Birkerød
- Website:
- https://www.virogates.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ViroGates A/S is an international medical technology company that develops and markets in vitro diagnostic blood tests for measuring chronic inflammation. Founded in 2000, its core technology is centered on the prognostic biomarker suPAR (soluble urokinase Plasminogen Activator Receptor). The company's products are sold under the suPARnostic® brand and are used for health risk assessment and to support clinical decision-making. Key markets include acute care, where the tests enhance patient triage and risk stratification; longevity, for assessing inflammation-driven aging and guiding personalized preventative care; and clinical research, to optimize patient selection and monitor intervention outcomes. The suPARnostic® product suite includes the Quick Triage point-of-care test, the Turbi-Latex solution for automated systems, and an ELISA assay for clinical and research applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all ViroGates A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ViroGates A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
